• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-08W
Device Problems Biocompatibility (2886); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 11/17/2023
Event Type  Injury  
Manufacturer Narrative
The complaint prodcut has not been analyzed yet since it has just arrived in japan.However, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and no similar event has been reported with this lot number globally so far.Since hypersensitivity occurred during treatment using the device, it was determined that a causal relationship "cannot be denied." the physician determined this event as "serious injury", and we also determined this event as "serious injury" since the patient was hospitalized.The cause of hypersensitivity might be an allergy to the membrane material of this product, but it cannot be determined.As for an allergic reaction, anaphylactoid reaction is described in ifu " e.Precautions 13.Monitor the patient constantly during treatment with the plasmaflo¿ op-05w(a).In the event of any of the following during treatment, immediately ensure the safety of the patient and take appropriate measures in accordance with the directions of the responsible physician.Presence of hemoglobin in separated plasma, due to hemolysis.The other potential reactions due to available substitute fluid such as fresh frozen plasma, plasma protein fraction are anaphylactoid reactions, hypocalcemia and infection." we are going to prepare a follow-up report as soon as we get the result of the analysis of the complaint product.We will continue to monitor the occurrence of similar events carefully.
 
Event Description
This incident occurred in france.Plasmaflo op is identical model to op-05w(a) marketed in us.This event occurred when double filtration plasmapheresis (dfpp) was performed on a patient using plasmaflo op.The patient was treated with dfpp for a recurrence of segmental and focal hyalinosis on a renal graft on (b)(6) 2023.20 minutes after starting the treatment, hypersensitivity such as tingling sensation in the lips, paresthesia on the tip of the tongue, nausea, vomiting, diarrhea, abdominal pain, and hypothermia appeared.Double filtration plasma exchange therapy was discontinued.Phloroglucinol, ondansetron, and paracetamol were administered as per ordered.Also, 500 ml of sodium chloride was administered via iv.The patient was hospitalized overnight and recovered.
 
Manufacturer Narrative
The inspection of the returned complaint product was completed at manufacturing site on december 27, 2023.According to the inspection, there were no abnormalities found and no similar event has been reported with this lot number globally so far.We will continue to monitor the occurrence of similar events carefully.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
2111-2 oaza sato
oita-sh
ioita, 870-0 396
JA   870-0396
Manufacturer Contact
naomi kagami
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key18333131
MDR Text Key330547692
Report Number8010002-2023-00040
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberOP-08W
Device Lot Number8M6S72
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Date Manufacturer Received11/24/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CASCADEFLO EC-30W.
Patient Outcome(s) Hospitalization;
Patient Age56 YR
Patient SexMale
Patient Weight94 KG
-
-